Stem Cell Trial

ISSCR - International Society for Stem Cell Research, 12th Annual Meeting in Vancouver, Canada, June 18-21, 2014

The Tisch MS Research Center presented two posters at the International Society for Stem Cell Research (ISSCR) 12th Annual Meeting last week based on the following study.

Safety and Dosing of Autologous Neural Progenitors Injected Intrathecally in Multiple Sclerosis Patients: Results of a Pilot Study

Saud A. Sadiq, and Violaine K. Harris

Stem Cell Trial Update: April 23, 2012

The Tisch MS Research Center of New Yorkis pleased to announce that it has successfully completed the initial steps towards accreditation to serve as a facility for the processing of human stem cells in clinical trials from the International Cellular Medicine Society. Along with soon-to-be-filed applications for additional certifications, this accreditation is an important step towards actually beginning the administration of neural progenitor stem cells to MS patients.

Subscribe to RSS - Stem Cell Trial